Covaxin production to ramped up to 12 mn using Bengaluru plant

 

by IANS | Wed, Apr 14, 2021, 11:41 AM

Bengaluru/Hyderabad, April 13 (IANS) Karnataka Health Minister K. Sudhakar on Tuesday welcomed Bharat Biotech's move to start manufacturing Covaxin coronavirus vaccine at its Bengaluru plant, amid reports it plans to double production to 12 mn by July.

In a tweet, the minister said that Bharat Biotech's decision to augment Covaxin production "will surely help India's massive Covid vaccination efforts".

Sources said that the Hyderabad-based company is ready to raise Covaxin production to 12 million doses a month from July from the current 5 million doses, through bulk production at its Bengaluru facility.

The company received approval to start bulk production at its Bengaluru facility recently.

According to official sources, Bharat Biotech has sought Rs 150 crore funding to be used in its Hyderabad and Bengaluru plants and thereby, propel vaccine production to 500 million doses eventually

Latest News
Opposition is disheartened after third phase: Yogi Adityanath Fri, May 10, 2024, 04:29 PM
Aggression without control can be detrimental': Courtney Walsh's pep talk to Kolhapur Tuskers' team Fri, May 10, 2024, 04:27 PM
Indian IT companies become more conservative in FY25 growth projections Fri, May 10, 2024, 04:26 PM
US, Egypt eye flexibility to reach Gaza deal Fri, May 10, 2024, 04:10 PM
Kerala BJP wants EC to take action against KPCC's fake video against PM Modi Fri, May 10, 2024, 04:05 PM